Introduction to Rahika 150mg Tablet
Rahika 150mg tablet contains the active ingredient Capmatinib. It is an anti-cancer medicine that belongs to the class of medications called protein kinase inhibitors. It is used to treat adults with a type of lung cancer called non-small cell lung cancer (NSCLC) that has spread to other body parts or is caused by a change (mutation) in a gene that makes an enzyme called MET in adults.
Do not take this medicine if you are allergic to Rahika 150mg tablet or any ingredients. Inform the physician if you have or have ever had lung or breathing problems other than your lung cancer, liver problems, or pancreatic problems. Inform your physician if you have any symptoms of an allergic reaction, including rash, hives, fever, difficulty breathing, or low blood pressure. This medicine is not recommended for children and adolescents below 18 years of age.
Avoid getting pregnant and breastfeeding during the treatment. Use effective contraception to avoid pregnancy. The common side effects of Rahika 150mg tablet are swelling in the face, and body, nausea, tiredness, vomiting, shortness of breath, and decreased appetite.
Therapeutic Effects of Rahika 150mg Tablet
Rahika 150mg tablet is a kinase inhibitor that targets mesenchymal-epithelial transition (MET). It works by blocking the action of this abnormal protein that signals cancer cells to multiply. This helps slow or stop the spread of cancer cells.
Interaction of Rahika 150mg Tablet with other drugs
Inform your healthcare provider about all the medicines you take, including prescription medications, over-the-counter medications, vaccinations, nutritional and vitamin supplements, and herbal products. Certain medications interact with Rahika 150mg tablet and reduce its effectiveness by causing undesirable side effects.
More Information about Rahika 150mg Tablet
- Store at 20°C to 25°C
- Protect the medicine from light and excessive moisture.
- Keep the medicine out of reach of children and pets
- If you forgot to take the tablet, take your next dose at the scheduled time. Do not take a double dose to make up for a forgotten dose.
How to consume Rahika 150mg Tablet
It is an orally available prescription drug. Your doctor will decide the dose and duration of Rahika 150mg tablet based on the disease condition and other factors. Always take this medicine as prescribed by your doctor. Take the tablet with or without food. Do not break, chew, crush, or break the tablet. Swallow the whole tablet with water.
Safety Advices for Rahika 150mg Tablet
Pregnancy
Do not take Rahika 150mg tablet if you are pregnant because this may harm the unborn baby. Inform your physician if you are pregnant, suspecting, or planning to get pregnant during the treatment. Use effective contraception during the treatment and for 7 days after your last dose.
Breast Feeding
Breastfeeding is not recommended in patients taking Rahika 150mg tablet because the medicine passes into the breast milk in small amounts and may harm your baby. Do not breastfeed during the treatment.
Lungs
Rahika 150mg tablet should be cautiously administered in patients with lung problems other than lung cancer. Inform your physician if you have any lung diseases before initiating the therapy.
Liver
Rahika 150mg tablet should be used cautiously in patients with liver problems. Dose adjustments are necessary for liver failure patients. Inform your physician if you have any liver diseases before initiating the therapy.
Alcohol
It is unknown whether it is safe to consume alcohol with Rahika 150mg tablet. Please consult your doctor.
Driving
It is unknown whether Rahika 150mg tablet alters the ability to drive or operate heavy machinery. If you feel dizzy or sleepy, avoid driving and consult your doctor.
Side Effects of Rahika 150mg Tablet
Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them.
Common
- Swelling in the face, and body
- Decrease in appetite
- Nausea
- Cough
- Fatigue
Serious
- Vomiting
- Liver injury
- Muscle pain
- Shortness of breath
- Lung infection
- Respiratory disease